Three Rivers Pharmaceuticals acquires Valeant Pharm Intl-Infergen(R) from Valeant Pharmaceuticals Intl


US - Three Rivers Pharmaceuticals LLC acquired the hepatitis C drug, Infergen, of Valeant Pharmaceuticals International, a manufacturer of pharmaceutical products, for $## mil in cash.

Deal Information

Credit & Investment Research

Market Research

News